Recent advances in cancer immunotherapy: Modulation of tumor microenvironment by Toll-like receptor ligands
Immunotherapy is considered a promising approach for cancer treatment. An important strategy for cancer immunotherapy is the use of cancer vaccines, which have been widely used for cancer treatment. Despite the great potential of cancer vaccines for cancer treatment, their therapeutic effects in cli...
Main Authors: | Leila Rostamizadeh, Ommoleila Molavi, Mohsen Rashid, Fatemeh Ramazani, Behzad Baradaran, Afsaneh Lavasanaifar, Raymond Lai |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences
2022-05-01
|
Series: | BioImpacts |
Subjects: | |
Online Access: | https://bi.tbzmed.ac.ir/PDF/bi-12-261.pdf |
Similar Items
-
Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives
by: Hao Sun, et al.
Published: (2022-12-01) -
Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives
by: Suprabhat Mukherjee, et al.
Published: (2023-09-01) -
Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments
by: Zhi-Mei Liu, et al.
Published: (2022-09-01) -
Reduced IL-8 Secretion by NOD-like and Toll-like Receptors in Blood Cells from COVID-19 Patients
by: Laura E. Carreto-Binaghi, et al.
Published: (2023-04-01) -
The critical role of Toll-like receptor-mediated signaling in cancer immunotherapy
by: Xue Chen, et al.
Published: (2022-06-01)